BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3023222)

  • 1. Effects of pro-opiomelanocortin-derived peptides on plasma levels of glucagon, insulin and glucose.
    Knudtzon J
    Horm Metab Res; 1986 Sep; 18(9):579-83. PubMed ID: 3023222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.
    Feldman M; Kiser RS; Unger RH; Li CH
    N Engl J Med; 1983 Feb; 308(7):349-53. PubMed ID: 6296674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of simultaneous or separate infusions of some pro-opiomelanocortin-derived peptides (beta-endorphin, melanocyte stimulating hormone, and corticotrophin-like intermediate polypeptide) and their acetylated derivatives upon sexual and ingestive behaviour of male rats.
    Hughes AM; Everitt BJ; Herbert J
    Neuroscience; 1988 Nov; 27(2):689-98. PubMed ID: 2851118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly.
    Hirsch MD; O'Donohue TL
    J Pharmacol Exp Ther; 1986 May; 237(2):378-85. PubMed ID: 2939234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
    Knudtzon J
    Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor is a downstream mediator of the beta-melanocyte-stimulating hormone-induced anorexigenic pathway in chicks.
    Kamisoyama H; Honda K; Saneyasu T; Sugahara K; Hasegawa S
    Neurosci Lett; 2009 Jul; 458(3):102-5. PubMed ID: 19393716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
    Knudtzon J
    Horm Metab Res; 1986 Aug; 18(8):505-9. PubMed ID: 2944808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-opiomelanocortin-derived peptides in the testis: evidence for a possible role in Leydig and Sertoli cell function.
    Boitani C; Chen CL; Margioris AN; Gerendai I; Morris PL; Bardin CW
    Med Biol; 1986; 63(5-6):251-8. PubMed ID: 2939305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pro-opiomelanocortin neuronal systems].
    Tranchand-Bunel D; Delbende C; Guy J; Jegou S; Jenks BJ; Mocaër E; Pelletier G; Vaudry H
    Rev Neurol (Paris); 1987; 143(6-7):471-89. PubMed ID: 3310184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effects of beta-endorphin on glucose metabolism in the rat.
    Matsumura M; Fukushima T; Saito H; Saito S
    Horm Metab Res; 1984 Jan; 16(1):27-31. PubMed ID: 6141988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood glucose control by direct islet innervation.
    Bloom SR
    Horm Metab Res; 1976; Suppl 6():85-90. PubMed ID: 819343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in normal-weight men.
    Ritter MM; Richter WO; Schwandt P
    Horm Metab Res; 1989 Jul; 21(7):383-6. PubMed ID: 2528500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in overweight women.
    Ritter MM; Richter WO; Schwandt P
    Horm Metab Res; 1992 Jul; 24(7):349-50. PubMed ID: 1516893
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of pro-opiomelanocortin products on the rat vas deferens.
    Smock T
    Life Sci; 1986 Nov; 39(18):1651-5. PubMed ID: 3022090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute in vivo stimulatory effects of human pituitary lipid-mobilizing factor on plasma levels of glucagon and insulin in rabbits.
    Knudtzon J; Winsnes A; Oyasaeter S; Foss I; Trygstad O
    Horm Metab Res; 1984 Dec; 16 Suppl 1():1-6. PubMed ID: 6398246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-melanocyte stimulating hormone increases plasma levels of glucagon and insulin in rabbits.
    Knudtzon J
    Life Sci; 1984 Feb; 34(6):547-54. PubMed ID: 6141515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus.
    Giugliano D; Ceriello A; Salvatore T; Paolisso G; D'Onofrio F; Lefèbvre P
    J Clin Endocrinol Metab; 1987 May; 64(5):944-8. PubMed ID: 2951394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for homologous actions of pro-opiocortin products.
    Walker JM; Akil H; Watson SJ
    Science; 1980 Dec; 210(4475):1247-9. PubMed ID: 6254152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.